Strategic Global Advisors LLC Makes New Investment in HCA Healthcare, Inc. $HCA

Strategic Global Advisors LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 8,246 shares of the company’s stock, valued at approximately $3,215,000.

A number of other hedge funds and other institutional investors have also modified their holdings of HCA. Sumitomo Life Insurance Co. boosted its position in HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after buying an additional 20 shares during the last quarter. MJP Associates Inc. ADV lifted its stake in shares of HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after acquiring an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC increased its position in HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after purchasing an additional 21 shares during the period. Anchyra Partners LLC lifted its position in HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after purchasing an additional 21 shares during the period. Finally, Plato Investment Management Ltd grew its position in shares of HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after buying an additional 22 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Mizuho reduced their price target on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 28th. Jefferies Financial Group set a $450.00 target price on HCA Healthcare in a research note on Tuesday, July 14th. Morgan Stanley lowered their price target on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research note on Monday, July 27th. Finally, Wells Fargo & Company boosted their price objective on shares of HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $462.64.

HCA Healthcare Price Performance

NYSE HCA opened at $426.36 on Thursday. The stock’s 50-day moving average is $399.36 and its 200-day moving average is $442.21. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The firm has a market cap of $92.31 billion, a P/E ratio of 14.27, a P/E/G ratio of 1.49 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the prior year, the business earned $6.84 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 10.45%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.